- Home
- ATOS vs LOGC Comparison
ATOS vs LOGC Comparison
Compare ATOS & LOGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- LOGC
- Stock Information
- Founded
- ATOS 2009
- LOGC 2010
- Country
- ATOS United States
- LOGC United States
- Employees
- ATOS N/A
- LOGC N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- LOGC Catalog/Specialty Distribution
- Sector
- ATOS Health Care
- LOGC Consumer Discretionary
- Exchange
- ATOS Nasdaq
- LOGC Nasdaq
- Market Cap
- ATOS 174.8M
- LOGC 167.6M
- IPO Year
- ATOS 2012
- LOGC 2020
- Fundamental
- Price
- ATOS $1.19
- LOGC $6.92
- Analyst Decision
- ATOS Strong Buy
- LOGC
- Analyst Count
- ATOS 3
- LOGC 0
- Target Price
- ATOS $6.75
- LOGC N/A
- AVG Volume (30 Days)
- ATOS 738.2K
- LOGC 305.6K
- Earning Date
- ATOS 11-12-2024
- LOGC 11-07-2024
- Dividend Yield
- ATOS N/A
- LOGC N/A
- EPS Growth
- ATOS N/A
- LOGC N/A
- EPS
- ATOS N/A
- LOGC N/A
- Revenue
- ATOS N/A
- LOGC $96,000,000.00
- Revenue This Year
- ATOS N/A
- LOGC N/A
- Revenue Next Year
- ATOS N/A
- LOGC $422.91
- P/E Ratio
- ATOS N/A
- LOGC N/A
- Revenue Growth
- ATOS N/A
- LOGC N/A
- 52 Week Low
- ATOS $0.70
- LOGC $4.01
- 52 Week High
- ATOS $2.31
- LOGC $7.11
- Technical
- Relative Strength Index (RSI)
- ATOS 31.91
- LOGC 63.79
- Support Level
- ATOS $1.26
- LOGC $6.19
- Resistance Level
- ATOS $1.66
- LOGC $7.11
- Average True Range (ATR)
- ATOS 0.09
- LOGC 0.29
- MACD
- ATOS -0.03
- LOGC 0.02
- Stochastic Oscillator
- ATOS 4.08
- LOGC 75.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives a majority of its revenue from Europe and also has a presence in North America; South America, and other countries.